RS
RCEL icon

R Squared’s Avita Medical RCEL Stock Holding History

R Squared’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.5K Buy
22,883
+7,598
+50% +$32.8K 0.05% 408
2026
Q1 		$56.6K Buy
+15,285
New +$64.2K 0.03% 412
2025
Q1 		– Sell
-215
Closed -$2.75K – 1210
2024
Q4 		$2.75K Buy
+215
New +$2.54K ﹤0.01% 1425

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

R Squared's RCEL Position: Q2 2026 in Review

R Squared increased its Avita Medical (RCEL) stake by 50% in Q2 2026, buying an estimated $32.8K and bringing the position to 22,883 shares worth $94.5K. The position accounts for 0.05% of the portfolio, ranked #408.

R Squared first reported a position in RCEL in Q4 2024 and has held it in 3 quarters since. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • R Squared held 22,883 shares of Avita Medical worth $94.5K as of Q2 2026.
  • R Squared bought 7,598 Avita Medical shares in Q2 2026, an estimated $32.8K.
  • Avita Medical made up 0.05% of R Squared's portfolio in Q2 2026, its #408 holding.
  • R Squared first reported a position in Avita Medical in Q4 2024 and has held it in 3 quarters since.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.